Pharmaceuticals, Biotechnology and Life Sciences
PARIS–(BUSINESS WIRE)–Ermium Therapeutics SAS, a research-stage biotechnology company developing innovative therapies for auto-immune diseases is announcing today the expansion of the Company executive management team with the appointment of Dr Anneg…
PARIS–(BUSINESS WIRE)–Ermium Therapeutics SAS, a research-stage biotechnology company developing innovative therapies for auto-immune diseases is announcing today the expansion of the Company executive management team with the appointment of Dr Anneg…
PARIS–(BUSINESS WIRE)–Ermium Therapeutics SAS, a research-stage biotechnology company developing innovative therapies for auto-immune diseases is announcing today the expansion of the Company executive management team with the appointment of Dr Anneg…
2020 growth fueled by expansion into adult and pediatric care settings and the approval of an additional algorithm to power clinical decision-support software
BOSTON–(BUSINESS WIRE)–Etiometry, a leader in clinical decision-support software for the i…
PARIS–(BUSINESS WIRE)–Ermium Therapeutics SAS, a research-stage biotechnology company developing innovative therapies for auto-immune diseases is announcing today the expansion of the Company executive management team with the appointment of Dr Anneg…
DUBLIN–(BUSINESS WIRE)–ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations, today announce…
Positioned as Screening Platform for Efficient Use of Private, State and Federal Next Generation Sequencing (NGS) Resources to Enhance Variant Testing
Newly Developed PCR Panel Detects Specific Mutations to Focus Limited NGS Capacity on Most Impactf…
Positioned as Screening Platform for Efficient Use of Private, State and Federal Next Generation Sequencing (NGS) Resources to Enhance Variant Testing
Newly Developed PCR Panel Detects Specific Mutations to Focus Limited NGS Capacity on Most Impactf…
Positioned as Screening Platform for Efficient Use of Private, State and Federal Next Generation Sequencing (NGS) Resources to Enhance Variant Testing
Newly Developed PCR Panel Detects Specific Mutations to Focus Limited NGS Capacity on Most Impactf…
DUBLIN–(BUSINESS WIRE)–The “Fezolinetant (ESN364) – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.
“Fezolinetant (ESN364) – Emerging Insight and Market Forecast – 2030” the report provides co…